US Health Secretary Robert F. Kennedy Jr.’s vaccine policies and commentary largely appear to contradict his pledge to revamp ...

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children with medical conditions that put them at higher risk of severe illness.

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...

Moderna says its new bivalent vaccine is its "lead candidate for a Fall 2022 booster." Here, a vial of the company's COVID-19 vaccine sits on a table at a vaccination clinic in San Rafael, ...

A head-to-head study of coronavirus vaccines in the United States finds the Moderna vaccine is slightly more effective than Pfizer’s in real-life use in keeping people out of the hospital, and J ...

The Moderna vaccine was 93% effective against COVID-19 in children aged 12 to 17 after the first dose and 100% two weeks after the second dose, with no cases of COVID-19 reported among vaccinated ...

Moderna says it plans to seek emergency use authorization from the U.S. Food and Drug Administration for its COVID-19 vaccine in children under age 6.

A volunteer received an injection of Moderna’s vaccine candidate earlier this year.Credit...Henry Ford Health System, via Agence France-Presse — Getty Images The Massachusetts-based company ...

Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...